Cagrilintide hmoov

Cagrilintide yog ib qho hluavtaws ntev - ua haujlwm amylin receptor agonist peptide, tsim tshwj xeeb rau hauv - vitro endocrine thiab metabolic mechanism tshawb fawb. Nws muaj cov qauv tshwj xeeb polypeptide ib ntus, dav siv los npaj cov cell incubation daws rau amylin receptor ntsig txog cov qauv ntawm tes. Cov kws tshawb fawb siv cov khoom siv raw no los tshawb txog amylin-kev tswj hwm kev noj qab haus huv, kev ua kom lub plab zom mov ntawm tes qauv, kev ntsuas peptide stability thiab tshuaj peptide nruab nrab qhov ua tau zoo.
Raws li cov qauv kuaj qis- qhov kub thiab txias, qhov siab no - purity lyophilized hmoov tuav ruaj khov tawg tom qab rov tsim dua. Nws khaws cov khoom siv tshuaj zoo ib yam hauv cov txheej txheem physiological buffer test systems, muab cov ntaub ntawv siv tau zoo rau hauv -vitro receptor binding assay thiab peptide degradation research. Nws yog qhov tsim nyog rau ntev - ua yeeb yam peptide formulation ua ntej - kawm thiab peptide kev hloov kho kev tshawb nrhiav.

◆ Amylin Receptor Activation In{0}}Vitro Research
Ua haujlwm xws li hauv -vitro pharmacological additive rau cell incubation systems, simulates amylin receptor activation effect thaum lub sij hawm metabolic endocrine pharmacological soj ntsuam.

◆ Peptide Oxidative Degradation Stability Assessment
Siv raws li tus qauv peptide siv tshuaj los saib xyuas cov molecular oxidation thiab hydrolysis degradation nyob rau hauv txawv pH thiab kub nyob rau hauv cell -dawb kua tshuaj tiv thaiv ib puag ncig.

◆ Amylin Agonist Peptide Scaffold Building Block
Muab cov khoom siv ua haujlwm polypeptide molecular skeleton rau kev kuaj peptide organic synthesis, txhawb nqa kev hloov pauv ntawm peptide thiab cov qauv- kev tshawb fawb kev sib raug zoo.

◆ Physiological Buffer Reconstitution Compatibility
Yooj yim rau yaj hauv dilute acetic acid thiab PBS tsis nyob nruab nrab, tuaj yeem sib xyaw nrog cov ntsev simulation ntawm lub cev los npaj ntau yam - cov khoom hauv - vitro pharmacological kev daws teeb meem.